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journal homepage: http: / /www.pediatr -neonatol .comEDITORIALPneumococcal Nasopharyngeal ColonizationStreptococcus pneumoniae can cause various diseases such
as invasive meningitis, sepsis, arthritis, noninvasive otitis
media, and pneumonia. Preceding nasopharyngeal coloni-
zation with homologous strains is key for pneumococcal
diseases. Colonized microorganisms are asymptomatic to
the carriers, although they may disseminate to the envi-
ronment and become pathogenic to carriers or to other
community members.1
There are several mechanisms involved in pneumococcal
colonization.2 Pneumococcus has a polysaccharide capsule,
which protects it from phagocytosis. The cell wall under-
neath the capsule causes an intense inflammatory reaction,
but the capsule can partially protect it from the host
response. Some cell walleassociated surface proteins
contribute to the colonization (e.g., pneumococcal surface
adhesion A can bind to the respiratory epithelium without
inducing inflammation; choline-binding protein A can
interact with the polymeric Ig receptor; and pneumococcal
serine-rich repeat protein can promote bacterial aggrega-
tion and biofilm structures in the nasopharynx. The hydro-
phobic and electrostatic characteristics of the cell wall
facilitates adherence through a physiochemical interac-
tion. Pneumococcal neuraminidase decreases the viscosity
of the mucus and exposes N-acetyl-glycosamine receptors
on the respiratory epithelial cells, and thereby promotes
the binding of pneumococcal surface adhesion A.
Pneumococcus and other microorganisms (e.g., Haemo-
philus influenzae, Moraxella catarrhalis, Staphylococcus
aureus, Neisseria meningitides, and various hemolytic
streptococci) can colonize in the upper respiratory tract
and have a dynamic ecological balance. Interspecies
competition of colonization exists (e.g., pneumococcus
inhibits the colonization of H. influenzae, M. catarrhalis,
and S. aureus). Inter-serotype competition of pneumo-
coccal colonization has also been found, especially after
mass pneumococcal vaccination.3
Pneumococcal colonization carriage rates vary in
different geographic areas, age groups, and socioeconomic
and environmental conditions. The reported carriage rates
vary widely from less than 5% to more than 80%. The rates
seem to be higher in less-developed countries, but this is
not always true. The surveillance methods would influence1875-9572/$36 Copyright ª 2013, Taiwan Pediatric Association. Publish
http://dx.doi.org/10.1016/j.pedneo.2013.06.001the results. The carriage rate usually increases during the
first 2 years of age, peaks at age 3, and then declines.4
In this issue of Pediatrics and Neonatology, Assefa et al
report that nearly one-half of outpatient children below
3 years of age in northwest Ethiopia have S. pneumoniae
carriage. The carriage rate declines to one-third at 8e10
years old.5 Crowding, family size and income, daycare
attendance, smoking, ethnicity, antibiotic use, and immu-
nization are associated with the frequency of pneumo-
coccal carriage.
Since colonized pneumococcal strains are the main
source of disease, controlling carriage may reduce the
disease burden. Antibiotic use is unrealistic and may cause
a resistance problem. Vaccination seems to be a better
strategy. After the introduction of pneumococcal conju-
gate vaccination, epidemiologic studies show no significant
change in the pneumococcal carriage rate, but they show a
change in serotype replacement.6,7 The pneumococcal
vaccine includes some serotypes that easily invade
humans. The replaced serotypes may unfortunately still
maintain an invasive tendency. The currently available
vaccines cannot prevent invasive disease without
hampering nasopharyngeal colonization and increasing
other possible pathogenic serotypes or genotypes. The use
of pneumococcal surface-associated proteins (e.g., pneu-
mococcal surface adhesion A, pneumolysin, and autolysin)
would be a new vaccine strategy to solve this problem in
the future.
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